Skip to main content

Table 1 Demographic features of once- and twice-daily dosage groups

From: Comparison of the efficacy of once- and twice-daily colchicine dosage in pediatric patients with familial Mediterranean fever – a randomized controlled noninferiority trial

Characteristic Once-daily dosage group (n = 42) Twice-daily dosage group (n = 37)
Age,a years 7.90 ± 1.96 7.78 ± 2.00
Sex, F/M 21/21 19/18
Age of disease onset,a years 5.14 ± 2.90 5.05 ± 3.04
Age of disease diagnosis,a years 7.54 ± 2.50 7.51 ± 2.66
Consanguinity, % 16.6 16.2
Presence of FMF in family members, % 59.5 62.2
  1. FMF familial Mediterranean fever
  2. aMean ± SD